Global 1,3-Dimethyladamantane Market Growth 2025-2031
Description
The global 1,3-Dimethyladamantane market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
1,3-Dimethyladamantane is a colorless transparent liquid, hardly soluble in water, but soluble in ether, alcohol and other organic solvents. It is mainly used in the synthesis of medicine, etc., to manufacture memantine hydrochloride, etc.
United States market for 1,3-Dimethyladamantane is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for 1,3-Dimethyladamantane is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for 1,3-Dimethyladamantane is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key 1,3-Dimethyladamantane players cover Evonik, Actylis, Glentham Life Sciences, VIO Chemicals AG, Matrix Fine Chemicals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “1,3-Dimethyladamantane Industry Forecast” looks at past sales and reviews total world 1,3-Dimethyladamantane sales in 2024, providing a comprehensive analysis by region and market sector of projected 1,3-Dimethyladamantane sales for 2025 through 2031. With 1,3-Dimethyladamantane sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world 1,3-Dimethyladamantane industry.
This Insight Report provides a comprehensive analysis of the global 1,3-Dimethyladamantane landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on 1,3-Dimethyladamantane portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global 1,3-Dimethyladamantane market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for 1,3-Dimethyladamantane and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global 1,3-Dimethyladamantane.
This report presents a comprehensive overview, market shares, and growth opportunities of 1,3-Dimethyladamantane market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Purity ≥ 98%
Purity ≥ 99%
Segmentation by Application:
Pharmaceutical Synthesis
Memantine Hydrochloride
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Evonik
Actylis
Glentham Life Sciences
VIO Chemicals AG
Matrix Fine Chemicals
Discovery Fine Chemicals
Chemical Line Co. Ltd
Changzhou Pesan Chemical Co.,Ltd
Hefei Heyu Chemical New Materials Co., Ltd
Nanjing Shunxiang Pharmaceutical Technology Co.,Ltd
Anstar New Material
Tianjin Minxiang Biomedical Inc
Shanghai Massive Chemical Technology Co., Ltd
Hubei Chushengwei Chemical Co., Ltd
NANJING TENGXIANG IMP&EXP CO.,LTD
JinXiang Chemical Factory
HUBEI XINMINGTAI PHARM CO.,LTD
Jinan Qinmu Fine Chemical Co.,Ltd
HeBei GuanLang Biotechnology Co.,Ltd
Key Questions Addressed in this Report
What is the 10-year outlook for the global 1,3-Dimethyladamantane market?
What factors are driving 1,3-Dimethyladamantane market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do 1,3-Dimethyladamantane market opportunities vary by end market size?
How does 1,3-Dimethyladamantane break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
1,3-Dimethyladamantane is a colorless transparent liquid, hardly soluble in water, but soluble in ether, alcohol and other organic solvents. It is mainly used in the synthesis of medicine, etc., to manufacture memantine hydrochloride, etc.
United States market for 1,3-Dimethyladamantane is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for 1,3-Dimethyladamantane is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for 1,3-Dimethyladamantane is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key 1,3-Dimethyladamantane players cover Evonik, Actylis, Glentham Life Sciences, VIO Chemicals AG, Matrix Fine Chemicals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “1,3-Dimethyladamantane Industry Forecast” looks at past sales and reviews total world 1,3-Dimethyladamantane sales in 2024, providing a comprehensive analysis by region and market sector of projected 1,3-Dimethyladamantane sales for 2025 through 2031. With 1,3-Dimethyladamantane sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world 1,3-Dimethyladamantane industry.
This Insight Report provides a comprehensive analysis of the global 1,3-Dimethyladamantane landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on 1,3-Dimethyladamantane portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global 1,3-Dimethyladamantane market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for 1,3-Dimethyladamantane and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global 1,3-Dimethyladamantane.
This report presents a comprehensive overview, market shares, and growth opportunities of 1,3-Dimethyladamantane market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Purity ≥ 98%
Purity ≥ 99%
Segmentation by Application:
Pharmaceutical Synthesis
Memantine Hydrochloride
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Evonik
Actylis
Glentham Life Sciences
VIO Chemicals AG
Matrix Fine Chemicals
Discovery Fine Chemicals
Chemical Line Co. Ltd
Changzhou Pesan Chemical Co.,Ltd
Hefei Heyu Chemical New Materials Co., Ltd
Nanjing Shunxiang Pharmaceutical Technology Co.,Ltd
Anstar New Material
Tianjin Minxiang Biomedical Inc
Shanghai Massive Chemical Technology Co., Ltd
Hubei Chushengwei Chemical Co., Ltd
NANJING TENGXIANG IMP&EXP CO.,LTD
JinXiang Chemical Factory
HUBEI XINMINGTAI PHARM CO.,LTD
Jinan Qinmu Fine Chemical Co.,Ltd
HeBei GuanLang Biotechnology Co.,Ltd
Key Questions Addressed in this Report
What is the 10-year outlook for the global 1,3-Dimethyladamantane market?
What factors are driving 1,3-Dimethyladamantane market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do 1,3-Dimethyladamantane market opportunities vary by end market size?
How does 1,3-Dimethyladamantane break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
135 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for 1,3-Dimethyladamantane by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for 1,3-Dimethyladamantane by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
